As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

Ascletis's news arrives shortly after Eli Lilly reported favourable Phase III weight loss data for its oral GLP-1RA, ...

Janelle Rohner claims she still followed her diet plan, noting GLP-1 weight loss drugs "don’t change your lifestyle overnight ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...

Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...

Ascletis has announced its oral glucagon-like peptide-1 receptor agonist (GLP-1RA) has achieved early weight loss in a Phase Ib trial and is now preparing to progress to a Phase IIa study.

The rise of GLP-1 weight loss drugs represents a shift in the way consumers approach their health goals The rise of GLP-1 drugs for weight loss represents a remarkable shift in the way people ...